North America
rBIO’s Biosimilar Insulin, R-biolin, Matches Novolin® R in Preclinical Studies; Company Moves Towards 50x Scale-Up and Human Trials
rBIO's biosimilar insulin, R-biolin, achieves bioequivalence to Novo Nordisk Novolin® R in animal studies; company prepares for 50x scale-up and readie...
February 05, 2025 | News
Nuvation Bio Launches Expanded Access Program in the U.S. for Taletrectinib in ROS1+ NSCLC
Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced it has initiated ...
February 04, 2025 | News
Tasso Inc. and ARUP Laboratories Partner in the U.S. to Expand At-Home Blood Testing for Clinical Research
Tasso Inc., the leading provider of patient-centric, clinical grade blood collection solutions, and ARUP Laboratories, the largest nonprofi...
February 04, 2025 | News
Cognizant and Medidata Expand AI-Driven Partnership to Advance Clinical Trials
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinica...
January 31, 2025 | News
Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform
Telix Pharmaceuticals Limited announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition inclu...
January 31, 2025 | News
CPC Introduces MicroCNX® Nano Series Connectors to Streamline Cell and Gene Therapy Processing
CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutic...
January 30, 2025 | News
Dräger’s Atlan® A350/A350XL Anesthesia Machines Earn Vizient Innovative Technology Designation in the U.S.
Dräger is proud to share that the Atlan® A350/A350XL Anesthesia Machines have received an Innovative Technology Product designation for anesthesia...
January 29, 2025 | News
Genialis Extends Collaboration with Debiopharm to Advance RNA-Based Biomarker for WEE1-Targeted Therapy
Genialis, the RNA biomarker company, announced an extension of its collaboration with Debiopharm, a Swiss-based global biopharmaceutical company, to develo...
January 29, 2025 | News
SOPHiA GENETICS Launches OncoPortal™ Mutation Tracker to Elevate Longitudinal MRD Monitoring in Oncology
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortal&...
January 29, 2025 | News
AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL...
January 28, 2025 | News
Akkodis Acquires Raland Compliance Partners to Expand Life Sciences Regulatory and Quality Expertise
Akkodis, a global digital engineering company and Smart Industry leader, today announced that it has acquired US-based Raland Compliance Partners, LLC (Ral...
January 24, 2025 | News
Novilytic Joins Forces with Avantor to Transform Drug Discovery with Proteometer® Platform
Novilytic, an innovator in molecular recognition technology, is proud to announce an exclusive distribution partnership with Avantor, a global supplier o...
January 23, 2025 | News
Hyundai ADM Bio Showcases Innovative Oral Chemotherapy OTX-M at Biotech Showcase 2025
Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug O...
January 23, 2025 | News
MicroAire Surgical Instruments Acquires NEOSYAD to Transform Adipose Tissue Engineering
MicroAire Surgical Instruments, the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical d...
January 21, 2025 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
